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Abstract
The uses of bionic devices that can improve the quality of human life are presented. Significant among them
are the bionic ear or the bionic eye which has helped to regain use of important sensory organs. Bionics is the
use of a biological entity and electronic devices that are put together to create the required implant.
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Can you imagine the personal impact that the restoration of
sound or sight brought about by the bionic ear or the bionic
eye would have on those dependent on such devices to regain
these critical senses? Or imagine the vast improvements in
the quality of life brought about by a neuroprosthetic device
that replaces a lost limb?
Such ambitions are no longer in the realm of science fiction.
A number of bionic devices are already available, the most
famous being the cochlear bionic ear implant pioneered by
Professor Graeme Clark.1 The bionic ear consists of a number
of critical components: a microphone that picks up the
sound, a speech processor that translates this into a series of
electrical impulses and electrodes that transmit this impulse
to the spiral ganglian cells in the cochlea. The effectiveness
of medical implants such as the bionic ear and others men-
tioned above is critically dependent on this electrode–
cellular interface and so the design, discovery and devel-
opment of new electromaterials are critical to the
enhancement of existing, and the development of new, bionic
devices.
These electromaterials provide the conduit for electrical
stimulation to be delivered to the biological environment. 
So what is bionics?
The effective integration of a biological entity and electronic
devices to create bionic structures is critical to create the
required seamless bridge between these two worlds. Another
challenge upon implantations of a bionic device is the elec-
tronic chasm created at the electrode–cellular interface, as
the immune response results in encapsulation of the foreign
body by fibrous tissue.
The first and perhaps most defining role the implant plays is
in determining the nature (composition and structure) of
this electrode–cellular interface. The composition of the
bionic device assembly must be such that it is not cytotoxic
and may, in fact, encourage the growth of certain cells over
others in the vicinity of the implant. The composition and
structure must also be such that appropriate mechanical
properties are available during the implant’s operational
lifetime. The composition and structure of the device also
determine its electronic properties, in particular conduc-
tivity (the ability to transport charge) and capacitance (the
ability to store charge). After implantation, the composition
and structure of the electrode–cellular interface dictate the
ability to inject/transfer charge into the biological system.
This will be determined by factors such as the cell types
present and this is dependent on the nature of the electrical
stimulation parameters used.2
Since the famous frog legs experiments conducted by Luigi
Galvani in 1783, the electrodes of choice for bionic appli-
cations have been based on inert metals. These include
platinum, as employed in the cochlear implant as well as in
most bionic eye studies, and iridium oxide.3 Alloys of Pt and
Ir have been utilised in deep brain simulator (DBS) elec-
trodes.4 Pt was first used as a recording electrode for the
cochlea in 19365 and in 1975 as a stimulating electrode by
Clark et al.6 for the cochlear implant. It was chosen because
it is inert and has low impedance and low cytotoxicity. Pt has
also been the material of choice for the development of the
bionic eye7,8 (Fig. 1), in which the Pt electrodes are used to
stimulate nerves in the retina. Iridium oxides have also been
shown to be suitable electrodes for retinal stimulation for
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Figure 1. Bionic eye approach. (We gratefully acknowledge the per-
mission of Bionic Vision Australia to use this image:
www.bionicvision.org.au.)
bionic eye applications.9 While Pt is a desirable metal for
implantable electrodes due to it low impedance properties in
vivo, its soft nature has its drawbacks. In order to improve its
strength without compromising impedance properties, Ir-Pt
alloys have been used. These alloys are frequently used in
neuro-stimulation and recording applications such as direct
neural sensory feedback and control of prosthetic limbs.10
Recently, nanostructuring of such electrodes has been
shown to improve performance by reducing impedance and
influencing cell compatibility.11
Since the discovery of organic conducting polymers just on
thirty years ago, researchers have devised a number of
approaches to control the chemical/biological, electronic/
electrochemical and mechanical properties. Control of each
of these is critical for the optimisation of the electrode–
cellular interface.
Given the degree of control thereby possible (see below), it is
hardly surprising that there is now a rapidly increasing
interest in the use of these organic conducting polymers to
help bridge the electronic chasm often faced by bionic
implants.
Organic bionics
Before discussing emerging applications for organic con-
ductors in medical bionics, we will take a brief look at the
control of implant properties through manipulation of the
molecules and materials used to produce these devices.
Finally, we will present some potential application areas for
bionic structures based on conducting polymers.
Molecules: chemical/biological properties
The chemistry of organic conducting polymers is primarily
dictated by the composition of the polymer backbone. There
are constraints in modifying this, in that to be electronically
conductive the polymer must have a conjugated backbone
and be amenable to doping (usually via oxidation to render p-
doping) at relatively low electrochemical potentials.
Some of the more commonly used p-doped organic con-
ducting polymers are show in Figure 2, where A– is a so-called
‘dopant’ anion incorporated to balance overall charge, and m
determines molecular weight.
N-doped materials do exist, but they usually require appli-
cation of a significant negative potential and such materials
are famously unstable.
The polyanilines are not usually considered for bionic appli-
cations since the aniline monomer from which they are syn-
thesised is only soluble at low pH and the polymer is usually
only conductive at low pH – both factors limit the possibilities
with respect to incorporation or attachment of biomolecules.
The pyrrole monomer is water soluble and hence polymer
assembly can be initiated in biologically friendly media. This
enables the incorporation/integration of biological entities
such as antibodies, enzymes or biological polyelectrolytes, or
other living cells at the time of polymerisation. Such an
approach enables the matching of the polymer with the bio-
logical environment of interest. Some of the biological
entities incorporated into polypyrrole (PPy) are summarised
in Table 1. We have recently developed protocols that enable
integration of nerve growth factors during the electrodepo-
sition of PPy. These neurotrophin-loaded materials have then
been used to facilitate interactions with nerve cells and
promote neurite outgrowth using electrical stimulation that
provides a direct effect as well as a means to control
localised release of the growth factor exactly where the
nerve cells are located. Electrical stimulation of PPy con-
taining a nerve growth factor has been shown to be highly
beneficial in promoting neurite outgrowth from cochlea
explants (Fig. 3).
It is fortunate that facile routes to adjust the conducting
polymer composition are at hand.  The more obvious route is
covalent attachment of groups to the polymer backbone.
However, this is not straightforward. In the case of pyrrole or
polypyrrole, this usually involves protecting and deprotecting
the –NH group on the pyrrole ring to direct substitution to
the 2- or 3-position. A number of bioactive functional groups
have been covalently attached to polypyrroles, usually after
polymerisation, to influence bioactivity. However, attachment
to the pyrrole ring can cause a marked decrease in the elec-
trical conductivity of the polymer. For example, covalent
attachment work22–24 compromises electronic properties –
Figure 2. Some commonly used p-type organic conducting polymers. 
A– represents anions, m determines molecular weight.
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compromising ability to transducer
biomolecular binding events.
For polythiophenes, the thiophene
monomers (thiophene, bithiophene or
terthiophene) are not water soluble, so
organic solvents are generally used for
polymerisation. On the other hand,
polythiophenes are more easily func-
tionalised than polypyrroles.25,26 Table
2 shows some examples of functional
groups covalently attached to poly-
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Figure 3. Experimental set-up for stimulating cochlea neurons in vitro (top). The chamber schematic
shows the explants sitting on the polypyrrole polymer doped with neurotrophins (Neurotrophin 3,
NT-3 and brain-derived neurotrophic factor, BDNF). Cochlea neuron explants cultured on
PPy/pTS/NT-3/BDNF polymers (bottom left and right) show growing neurites extending from the
explant cell body. Electrical stimulation increases the rate at which neurotrophins are released from
the polymer structure. The increased concentration of neurotrophins causes the explant to differ-
entiate to a greater extent. (Fluorescent images courtesy of Miss Brianna Thompson, ARC Centre of
Excellence for Electromaterials Science, University of Wollongong.)
Table 1 Biological entities incorporated into PPy
Bioentity Purpose Reference
Enzymes:
Horseradish peroxidase Amperometric detection of rifampicin 12
Glucose oxidase Amperometric detection of glucose 13, 14
Antibodies:
Anti-isoproturon Detection of the isoproturon pesticide in solution 15
Anti-human fibronectin Electrically controllable sensing platform 16
Biological polyelectrolytes:
Hyaluronic acid Support and stimulate cell growth 17
Chondroitin sulfate Support and stimulate cell growth 18
Neurotrophins Enhance neural differentiation 19–21
Table 2 Functional groups covalently attached to polythiophenes for improved
biomedical applications
Functionalisation entity Purpose Reference
Oligonucleotide Genosensor 27
Biotin Transducer for detection of avidin 28
Alkyl chains Change hydrophobicity of polymer for cellular interaction 29
Glucose oxidase Fabrication of electrodes for a glucose fuel cell 30, 31
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common form is as a film produced via electrodeposition in
which biomolecules are incorporated/attached using one of
the strategies described above. A more detailed discussion of
the protocols used for electrodeposition of each of these
monomers is available elsewhere.32
Electrodeposited films
Electrochemical formation of conducting polymers generally
results in the formation of an insoluble deposit on the
electrode. The composition of the material is dependent on
the electrolyte solution used in the polymerisation. For bionic
applications, an adherent film with good mechanical prop-
erties and high conductivity is desirable. While polymer com-
position (polymer backbone and the dopant, A–) obviously
will influence the resultant material properties, the electro-
chemical conditions (e.g. current density, applied potential)
and the substrate employed also have a great influence.32
Varying the dopant has been shown to greatly effect the
tensile strength of conducting polymers.33 Their mechanical
properties also vary with the concentration of dopant used in
the polymerisation solution. For example, Kaynak et al.34
demonstrated that the tensile strength of polypyrrole films
highly doped with p-toluenesulfonate were lower than that of
lightly doped ones. In addition, they showed that regardless
of doping level, the polymer breaking strain decreased upon
ageing, while the breaking stress, Young’s modulus and
toughness increased. The use of biological polyelectrolytes
such as dextran sulfate as the dopant is beneficial due to the
biological character imparted at the molecular level, and also
because of the formation of an electronically conducting
hydrogel with high water content.35
Electrically conducting hydrogels can also be formed by elec-
tropolymerising within a preformed gel (Fig. 436). The
support structure of the original gel is retained with water
content changing by only a few per cent after incorporation
of the conducting polymer.37 Processable (ethanol soluble)
hydrogels based on block copolymers of poly(ethylene oxide)
and poly(ε-caprolactone), or heat-extrudable gels based on
cross-linked poly(acrylic acid) have also been used as the
host matrix for conducting polymers.38
Martin and co-workers recently reported an ingenious
protocol that allows formation of a conducting polymer in
the presence of living cells (neuroblastoma-derived cells) in
vitro,39 they further demonstrated the ability to polymerise a
conducting polymer in living neural tissue in vitro.40 This
opens up the intriguing possibility of electropolymerisation
of conducting polymers in vivo. These novel approaches
enable, for the first time, the seamless integration of an
Figure 4. Process for fabricating conducting polymers–hydrogel composite.
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electrode with living cells. Conducting polymers, PEDOT and
polypyrrole have also been evaluated in vivo with promising
results indicating good biocompatibility41 with the ability to
measure clinically relevant levels of chemical species in real
time in such organs as the brain.42
Spinning fibres
For some bionic applications, alternative material forms are
required. Another attractive option therefore involves the use
of more soluble, processable conducting polymers. The use of
nano- or micro-dimensional fibres is of particular interest
when directional cues for cell growth are required.
Electrospinning nanofibres
The use of electrospinning (Fig. 5) to produce nanofibres has
been explored for biomaterials used in vascular grafts,
wound dressings and tissue engineering scaffolds.43
Electrospinning has been widely used for making non-woven,
small-diameter, fibro-porous materials. It involves injecting
charge into a polymer solution (typically 5–40 kV) contained
in a syringe. Pressure is slowly applied to the syringe, forcing
the polymer solution to the tip of the syringe needle. The
charged polymer solution, at the needle tip, is separated from
a second electrode (collecting substrate) of opposite polarity
to generate an electric field. The charged polymer solution
forms a Taylor cone due to competing forces generated in the
static electric field and the polymer solution’s surface
tension. These forces cause charged fibres to disperse from
the Taylor cone towards the collecting plate. Electrospun
fibres have been prepared from biocompatible non-con-
ducting polymers such as poly(lactic acid)/poly(lactic-co-
glycolic acid) (PLA/PLGA)44 and polyurethane.45 The desire
to impart additional functionality into electrospun fibres has
recently resulted in the fabrication of conducting polymer
fibres.46 Significantly, nanofibres containing the conducting
polymer polypyrrole were fabricated into mats that suc-
cessfully supported the growth of PC12 cells in vitro.47
Wet spinning fibres
The technique of wet spinning has been used for many years
to produce fibres for the textile industry. In more recent
times, researchers have used this technique to produce fibres
from a variety of polymers48,49 and polysaccharides50 for use
in a range of biomedical applications. These fibres have also
been made electrically conducting by the incorporation of
carbon nanotubes51–53 and conducting polymers.54–56 Wet
spinning offers the attractive feature of producing long
lengths of fibres with uniform properties (conductivity and
strength) along their length in one experimental run. These
novel conducting fibres are now being investigated as
suitable materials to be interfaced with cells to form com-
ponents of bionic applications, such as stimulated drug
delivery as well as neural growth and differentiation.
Medical devices
Extraordinary advances have already been made with
medical devices using more conventional electrode
materials. Piersma and Greatbatch57 performed a compre-
hensive study of over thirty metals, alloys and other
materials in simulated physiological conditions using gal-
vanostatic pulses typically employed by cardiac pacemakers.
They classified pacemaker electrode materials into five
groups representing different electrochemical processes:57
1 platinum group metals and alloys that exhibit no meas-
urable dissolution and couple at the electrode–tissue
interface by means of oxygen adsorption
2 valve metals like titanium and tantalum that undergo cor-
rosion of the bare metal but are protected by an irre-
Figure 5. Electrospinning set-up (left) showing the resulting porous mat (right). The polymer in the syringe is dispensed at a set flow rate and a voltage
(V) is applied between the syringe needle and the metal collecting substrate which is kept at a constant separation distance (d).
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versibly formed oxide which cannot be electrochemically
reduced
3 silver and similar materials that react with chloride ion,
resulting in a metal chloride-metal ion equilibrium and an
almost ideally non-polarisable electrode system
4 alloys of iron or cobalt that can experience significant dis-
solution under certain conditions and apparently do not
couple by a reversible oxygen mechanism
5 carbon, which has current–voltage behaviour very similar
to the platinum metals but which may have a different
coupling mechanisms.
This comprehensive study enables researchers to choose the
correct electrode material to match the bionic application
and environment in which the electrode will be used.
For the cochlear implant (bionic ear) and bionic eye devices
the metal of choice is platinum. The cochlear implant utilises
twenty-two banded Pt electrodes (Fig. 6) while the most
advanced bionic eye prototype utilises an electrode array
comprising 60-micron-sized Pt pad electrodes. The Pt band
electrode of the cochlear implant shows remarkable stimu-
lating properties over years of operation with negligible
increase in impedance. While the bionic eye is yet to undergo
large-scale trials, the early indications suggest that the Pt
pad electrodes perform as well in vivo as the cochlear
implant electrodes.
The use of stimulating electrodes implanted into a patient’s
muscle to operate prosthetic limbs enables the user to
manoeuvre the prosthetic via natural muscle contraction and
relaxation triggered through normal neural path ways. In
order for a robotic prosthetic limb to work, it must have
several components to integrate it into the body’s function.
The electrodes (biosensors) detect signals from the user’s
nervous or muscular systems and relay this information to a
controller located inside the device. They also process
feedback from the limb and actuator (e.g. position, force) and
send it to the controller. Electrode examples include wires
that detect electrical activity on the skin, needle electrodes
implanted in muscle, and solid-state arrays with nerves
growing through them. One type of electrode is the elec-
tromyographic electrode (Epimysial), which consists of a
platinum–iridium disk mounted in a silicone backing rein-
forced with Dacron.58
A bionic device has the capability to stimulate cells/tissue to
initiate a response, such as contraction in muscle tissue or
acceleration of cellular proliferation. These applications of
bionic devices have been utilised for muscle and bone regen-
eration. Electrical stimulation of muscle cells and muscle
tissue has been investigated in in vivo and in vitro envi-
ronments, respectively. A range of electrode materials have
been employed, such as carbon rods,59 Pt-Ir60 and a bilayer
of Ti and Au.61
To initiate bone growth, there are two types of bone growth
stimulators: one that sits on the outside of the skin and
utilises electromagnetic fields, and an implantable (in vivo)
system that utilises direct bone-pulsed current stimulation.
The material of choice for the in vivo electrodes include
titanium62 and stainless steel.63 In vivo bone growth stimu-
lation has been shown to produce new bone growth twice as
fast as untreated fractures. Much research has been
undertaken to accurately map the electric fields generated
in bone.64 As a result, the effects of electrode shape, size and
material of the stimulating electrode on bone regrowth are
well characterised.
Conclusions and future developments
The world of bionics should be revolutionised in the next few
decades.  Astounding advances in electronics and materials
science will undoubtedly impact on our ability to influence
the biological world using electronics. The development of
highly effective devices such as the bionic eye9 and the
bionic ear,1,2 as well as the ability to integrate prosthetic
devices with neural control58 or to use bionic devices in
regenerative medicine will have tremendous implications for
individuals and the society in which they live.
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Figure 6. Internal components of the cochlear implant showing a close-
up of some of the twenty-two Pt bands in the stimulating electrode array.
Image courtesy of Cochlear Ltd 2009.
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